RCOR3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.015800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.819400E-01
Normal-vs-Stage2
6.491900E-02
Normal-vs-Stage3
5.322400E-02
Normal-vs-Stage4
4.076000E-01
Stage1-vs-Stage2
2.153000E-01
Stage1-vs-Stage3
2.880000E-02
Stage1-vs-Stage4
7.658800E-01
Stage2-vs-Stage3
1.033180E-01
Stage2-vs-Stage4
4.905600E-01
Stage3-vs-Stage4
3.575900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.587600E-02
Normal-vs-AfricanAmerican
3.807000E-01
Normal-vs-Asian
2.233000E-01
Caucasian-vs-AfricanAmerican
8.046600E-01
Caucasian-vs-Asian
8.381800E-01
AfricanAmerican-vs-Asian
9.197800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.270450E-01
Normal-vs-Female
5.013600E-02
Male-vs-Female
3.328800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.746000E-01
Normal-vs-Age(41-60Yrs)
9.119600E-02
Normal-vs-Age(61-80Yrs)
9.514400E-02
Normal-vs-Age(81-100Yrs)
1.006180E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.444800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.789200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.975200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.749030E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.013800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.630800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.861700E-02
Normal-vs-Daily Drinker
8.111900E-02
Normal-vs-Weekly Drinker
1.458440E-01
Normal-vs-Occasional Drinker
5.342200E-01
Normal-vs-Social Drinker
1.379350E-01
Non Drinker-vs-Daily Drinker
8.088800E-01
Non Drinker-vs-Weekly Drinker
5.694400E-01
Non Drinker-vs-Occasional Drinker
6.230200E-02
Non Drinker-vs-Social Drinker
6.977600E-01
Daily Drinker-vs-Weekly Drinker
7.390200E-01
Daily Drinker-vs-Occasional Drinker
7.180200E-02
Daily Drinker-vs-Social Drinker
5.923400E-01
Weekly Drinker-vs-Occasional Drinker
9.462100E-02
Weekly Drinker-vs-Social Drinker
4.742800E-01
Occasional Drinker-vs-Social Drinker
2.260400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.286200E-02
Normal-vs-Grade 2
7.241000E-04
Normal-vs-Grade 3
2.438500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.666400E-01
Grade 1-vs-Grade 3
3.989600E-01
Grade 1-vs-Grade 4
2.286200E-02
Grade 2-vs-Grade 3
1.621560E-01
Grade 2-vs-Grade 4
7.241000E-04
Grade 3-vs-Grade 4
2.438500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.368100E-02
Normal-vs-NonDiabetic
8.964100E-02
Diabetic-vs-NonDiabetic
6.774100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.656300E-02
Normal-vs-NoPancreatitis
8.853700E-02
Pancreatitis-vs-NoPancreatitis
4.725600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.082800E-01
Normal-vs-N1
4.695700E-02
N0-vs-N1
1.367410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.062200E-01
Normal-vs-TP53-NonMutant
3.710400E-01
TP53-Mutant-vs-TP53-NonMutant
9.136600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
